|C.Domain Capital||Beijing, Beijing, China|
|Crohn's & Colitis Foundation of America||Hatfield, Hertfordshireshire, United Kingdom|
|Fuhai Yintao||China, Guangdong, Shenzhen|
|Future Positive Capital||France, Ile-de-France, Paris|
|HIVE||California, San Francisco, United States|
|Jiaxing Pucheng Gquan Touzi Hehuoqiye||China, Jiaxing, Zhejiang|
|Kingson Capital Partners||Durban, KwaZulu-Natal, South Africa|
|Nippon Columbia||Japan, Minato|
|Norwegian Research Council||Norway, Oslo|
|Robbins Venture Capital||Elizabethtown, Kentucky, United States|
|Shefa Capital||Israel, Tel Aviv, Tel Aviv District|
|Silicon Solution Ventures||-|
|Sunrise Capital Partners||New York, New York, United States|
|Valquest Partners||Beirut, Beyrouth, Lebanon|
|Viva BioInnovator||China, Shanghai|
|Waterlow Management Ltd||England, London, United Kingdom|
|$30M||12 Jul 2022||Virginia, United States|
|$8M||10 Jan 2020||Virginia, United States|
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.